Literature DB >> 18617412

Is histological diagnosis necessary to start treatment for germ cell tumours in the pineal region?

Masayuki Kanamori1, Toshihiro Kumabe, Teiji Tominaga.   

Abstract

The significance of histological diagnosis was retrospectively investigated in the treatment of 79 consecutive patients with pineal region tumours. Histological diagnoses were consistent with clinical diagnoses in 38 out of 39 patients with germ cell tumours and in all eight patients with non-germ cell tumours. The single exception was pineoblastoma. Forty-one patients were treated under a clinical diagnosis of pineal germ cell tumour using neoadjuvant chemotherapy and radiation therapy without histological verification. Of the 41 patients, 32 achieved an excellent response, whereas nine required the delayed resection of a residual tumour. Of these nine tumours, seven were mature or immature teratomas or scars. These patients had elevated levels of tumour markers. Most cases of pineal germ cell tumour could be identified on the basis of clinical findings only, and could be treated appropriately using neoadjuvant chemotherapy and radiation therapy without histological diagnosis. However, second-look surgery should be considered in cases with residual teratomatous components or unusual responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617412     DOI: 10.1016/j.jocn.2007.08.004

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  7 in total

1.  Neuroendoscopy in the management of pineal region tumours in children.

Authors:  Chandrashekhar Deopujari; Krishna Shroff; Vikram Karmarkar; Chandan Mohanty
Journal:  Childs Nerv Syst       Date:  2022-06-03       Impact factor: 1.475

2.  Indications for salvage surgery during treatment for intracranial germ cell tumors.

Authors:  Masayuki Kanamori; Toshihiro Kumabe; Mika Watanabe; Masashi Chonan; Ryuta Saito; Yoji Yamashita; Yoshikazu Ogawa; Yukihiko Sonoda; Teiji Tominaga
Journal:  J Neurooncol       Date:  2018-03-26       Impact factor: 4.130

3.  So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?

Authors:  Masayuki Kanamori; Hirokazu Takami; Shigeru Yamaguchi; Takashi Sasayama; Koji Yoshimoto; Teiji Tominaga; Akihiro Inoue; Naokado Ikeda; Atsushi Kambe; Toshihiro Kumabe; Masahide Matsuda; Shota Tanaka; Manabu Natsumeda; Ken-Ichiro Matsuda; Masahiro Nonaka; Jun Kurihara; Masayoshi Yamaoka; Naoki Kagawa; Naoki Shinojima; Tetsuya Negoto; Yukiko Nakahara; Yoshiki Arakawa; Seiji Hatazaki; Hiroaki Shimizu; Atsuo Yoshino; Hiroshi Abe; Jiro Akimoto; Yu Kawanishi; Tomonari Suzuki; Atsushi Natsume; Motoo Nagane; Yukinori Akiyama; Dai Keino; Tadateru Fukami; Takahiro Tomita; Kohei Kanaya; Tsutomu Tokuyama; Shuichi Izumoto; Mitsutoshi Nakada; Daisuke Kuga; Shohei Yamamoto; Ryogo Anei; Takeo Uzuka; Junya Fukai; Noriyuki Kijima; Keita Terashima; Koichi Ichimura; Ryo Nishikawa
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

4.  Pituitary Stalk Germ Cell Tumors: Retrospective Case Series and Literature Review.

Authors:  Han Chen; Ming Ni; Yun Xu; Li-Yong Zhong
Journal:  Int J Endocrinol       Date:  2022-03-26       Impact factor: 3.257

5.  Misdiagnosis of elevation of β-hCG in cystic craniopharyngioma: illustrative case.

Authors:  Umaira Saleh; Liang Hooi Lim; Ihfaz Ismail; Nasser Abd Wahab
Journal:  J Neurosurg Case Lessons       Date:  2021-02-01

6.  Gamma knife radiosurgery (GKRS) for pineal region tumors: a study of 147 cases.

Authors:  Wentao Li; Binfei Zhang; Wenxing Kang; Boning Dong; Xudong Ma; Jinning Song; Yonghong Liu; Zhenqiang Liang
Journal:  World J Surg Oncol       Date:  2015-10-21       Impact factor: 2.754

7.  Treatment of primary intracranial germ cell tumors: Single center experience with 42 clinically diagnosed cases.

Authors:  Qun-Ying Yang; Cheng-Cheng Guo; Mei-Ling Deng; Jian Wang; Jing Wang; Fu-Hua Lin; Ji Zhang; Xiao-Bing Jiang; Yong-Gao Mou; Zhong-Ping Chen
Journal:  Oncotarget       Date:  2016-09-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.